Kiwi Wealth Investments Limited Partnership Celldex Therapeutics, Inc. Transaction History

Kiwi Wealth Investments Limited Partnership

$126 Million
Q4 2023

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$20.5 - $37.33 $563,278 - $1.03 Million	-27,477 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$27.64 - $39.32 $677,124 - $963,261	-24,498 Reduced 47.13%	27,477 $936,000
Q4 2021 Feb 15, 2022	BUY	$35.68 - $56.27 $1.25 Million - $1.97 Million	35,073 Added 207.51%	51,975 $2.01 Million
Q3 2021 Nov 16, 2021	BUY	$28.95 - $55.99 $489,312 - $946,342	16,902 New	16,902 $913,000

Others Institutions Holding CLDX

# of Institutions

207

Shares Held

67.3M

Call Options Held

1.69M

Put Options Held

980K

Wellington Management Group LLP Boston, MA

9.24M
Shares

$250 Million
0.06% of portfolio
Black Rock Inc. New York, NY

4.69M
Shares

$127 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.87M
Shares

$105 Million
0.0% of portfolio
Kynam Capital Management, LP Princeton, NJ

3.46M
Shares

$93.5 Million
9.64% of portfolio
Eventide Asset Management, LLC Boston, MA

3.33M
Shares

$90 Million
1.99% of portfolio

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.26B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kiwi Wealth Investments Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Kiwi Wealth Investments Limited Partnership with notifications on news.

Account